144829-96-9

Basic information

• Product Name: FMoc-DL-proline
• Synonyms: FMoc-DL-proline;DL-Fmoc-Proline;1-(((9H-fluoren-9-yl)methoxy)carbonyl)pyrrolidine-2-carboxylic acid;N-±-Fmoc-proline
• CAS NO: 144829-96-9
• Molecular Formula: C₂₀H₁₉NO₄
• Molecular Weight: 337.36916
• Mol File: 144829-96-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: FMoc-DL-proline(CAS DataBase Reference)
• NIST Chemistry Reference: FMoc-DL-proline(144829-96-9)
• EPA Substance Registry System: FMoc-DL-proline(144829-96-9)

Safety Data

• Hazardous Substances Data: 144829-96-9(Hazardous Substances Data)

Upstream product

• 28920-43-6 (fluorenylmethoxy)carbonyl chloride 
• 109-70-6 1.3-chlorobromopropane 
• 82911-69-1 N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide 
• 609-36-9 rac-Pro-OH 

Downstream Products

• 127492-90-4 Ava-Phe-Phe-D-Pro-Leu-Met-NH₂ 
• 144073-24-5 Fmoc-D-Pro-L-Pip-D-(N-Me)Phe-L-Pro-OCH₂Ph 
• 183742-76-9 (S)-2-{[(R)-1-((S)-2-{[(2R,3R,4R,5S,6R)-3-((S)-2-Amino-propionylamino)-4,5-bis-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-carbonyl]-amino}-propionyl)-pyrrolidine-2-carbonyl]-amino}-propionic acid 
• 171905-37-6 (R)-(9H-fluorene-9-yl)methyl 2-(chlorocarbonyl)pyrrolidine-1-carboxylate 
• 157610-37-2 H-Ala-Ala-D-Trp-Phe-D-Pro-Pro-Nle-NH₂ 

Relevant articles and documents

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF

A compound represented by Formula [1] (in the formula, Z1 represents N, CH, or the like; X1 represents NH or the like; R1 represents a heteroaryl group or the like; each of R2, R3, and R4 represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R5 represents a heteroaryl group or the like) or salt thereof.

Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same

The invention relates to transport molecule binding ligand compounds which comprise a therapeutically and/or diagnostically active substance and a carrier molecule-affine substance with a high association constant to the carrier molecule. The invention also relates to medicaments containing these ligand compounds and to diagnostic kits.